ZURICH (Reuters)—Novartis AG has struck a $170 million alliance with U.S.-based Surface Oncology as it seeks to boost its portfolio of medicines that help the body’s immune system fight cancer. The accord, which it announced on Monday, gives Novartis access to four pre-clinical programs aiming to help prevent tumors from evading the immune system, including…
Healthcare Investors Brace for Busy Week as U.S. Conference Kicks Off
(Reuters)—Healthcare investors can expect a volatile week starting on Monday when the sector’s biggest financial event hits San Francisco. The annual JP Morgan healthcare conference, in which many healthcare companies present product and financial news to would-be investors, has been credited for helping the January out-performance of the healthcare sector in recent years. But after…
Study Uncovers Tet2’s Role in Resolving Inflammation
When investigating the role of epigenetic modifiers in inflammatory response, researchers found that Tet2 acts at the chromatin level to help resolve inflammation in both dendritic cells and macrophage, repressing the transcription of IL-6…
Overscreening, Overtreatment of Osteoporosis Common
NEW YORK (Reuters Health)—Too many women who aren’t at risk for osteoporosis are being screened for the disease, and too many women who don’t need osteoporosis treatment are getting it, new research suggests. “In our health system the overtreatment of osteoporosis was common, and this was partly due to the fact that a lot of…
Do Tiered Physician Networks Help or Hurt? What Rheumatologists Should Know
Health insurance plans are increasingly favoring tiered physician networks, which some fear have the potential to limit patient access to such specialties as rheumatology to achieve short-term cost reduction…
New York Orders UnitedHealth to Pay $100,000 to Settle Antitrust Probe
WASHINGTON (Reuters)—The New York Attorney General has ordered UnitedHealth Group to pay a $100,000 fine after an investigation found the insurance provider engaged in anti-competitive practices involving elder and long-term care products, according to a person familiar with the matter. The settlement, which was signed late Wednesday, centers on efforts by UnitedHealth to force nursing…
Patients Leaving Hospitals Often Don’t Understand Care Plans
(Reuters Health)—Many patients leaving the hospital don’t understand follow-up care plans because the instructions are tailored to people with higher reading levels and more education, a recent U.S. study suggests. The American Medical Association already recommends that written health information be targeted to a sixth grade audience because nearly half of the U.S. population is…
Living with RA: Study Examines the Value of Patient Involvement in Creating Clinical Practice Guidelines
“The lived experience with RA is itself a valuable form of expertise,” writes Dr. Liana Fraenkel, MD, MPH, and her colleagues in their latest research. To examine the value of this expertise and how it can be incorporated into clinical practice guidelines, researchers developed 18 questions for which two panels—one physician dominated and one comprising entirely patients—would develop recommendations. For a majority of these questions, the patient panel made the same recommendations as the physician panel, with similar recommendation strengths…
Biosimilars Seek Regulatory Approval in the U.S. & Europe; Plus MTX Underused in the U.S.
In Europe, an etanercept biosimilar is getting closer to being approved to treat RA and more, and in the U.S., an application for an adalimumab biosimilar has been submitted for FDA approval. Also, an analysis of methotrexate use in the U.S. shows that therapy may actually be underused for RA…
5 Considerations to Help Jumpstart Your New Rheumatology Practice
Starting your own rheumatology practice is daunting, and it’s easy to focus on the medical side and neglect the business side of a practice. Here are five important considerations that could help a new practice thrive…
- « Previous Page
- 1
- …
- 531
- 532
- 533
- 534
- 535
- …
- 814
- Next Page »